Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bioxcel Therapeutics Inc (NQ: BTAI )

34.04 USD +0.88 (+2.65%)
Official Closing Price Updated: 5:16 PM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Bioxcel Therapeutics Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
66 Biggest Movers From Friday
Gainers Senmiao Technology Ltd (NASDAQ: AIHS) shares climbed 151.8% to close at $1.07 on Friday after the company reported Q2 EPS ... 
Tags APDN CRVS AIHS
From Benzinga
The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit ... 
Tags STIM OCX Earnings
From Benzinga
BioXcel Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and... 
From Business Wire News Releases
Benzinga's Top Upgrades, Downgrades For November 12, 2019
Upgrades Keefe, Bruyette & Woods changed the rating for Argo Group International Holdings Ltd (NYSE: ARGO) from Market Perform ... 
Tags Upgrades CNMD CTVA
From Benzinga
BioXcel Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and Webcast
BioXcel Therapeutics, Inc. (“BTI” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and... 
From Business Wire News Releases
BioXcel Therapeutics to Present at the 26th Annual Prostate Cancer Foundation Scientific Retreat
BioXcel Therapeutics, Inc. (“BTI” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company utilizing novel artificial intelligence approaches to identify and advance the... 
From Business Wire News Releases
BioXcel Therapeutics Highlights Upcoming Major Milestones
From GlobeNewswire News Releases
Relative Strength Alert For BioXcel Therapeutics
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
50 Biggest Movers From Yesterday
Gainers Precipio, Inc. (NASDAQ: PRPO) shares rose 50% to close at $3.27 on Thursday following press release highlighting clinical ... 
Tags General URGN SNDL
From Benzinga
Mid-Afternoon Market Update: Crude Oil Down 1%; Marinus Pharmaceuticals Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 0.03% to 26961.38 while the NASDAQ fell 0.46% to 8040.00. The S&P also fell, ... 
Tags PSO Mid/Afternoon Market Update RAD
From Benzinga
34 Stocks Moving In Thursday's Mid-Day Session
Gainers Rite Aid Corporation (NYSE: RAD) jumped 25.1% to $9.67 after the company reported stronger-than-expected earnings for its ... 
Tags Mid/Day Movers NBR FUL
From Benzinga
Mid-Day Market Update: Rite Aid Surges On Earnings Beat; BioXcel Therapeutics Shares Slide
Midway through trading Thursday, the Dow traded down 0.17% to 26925.28 while the NASDAQ fell 0.38% to 8046.63. The S&P also fell, ... 
Tags ENTA BYND RAD
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Conagra Brands Earnings Beat Estimates
Following the market opening Thursday, the Dow traded down 0.16% to 26928.06 while the NASDAQ fell 0.56% to 8032.25. The S&P also ... 
Tags PCG News Global
From Benzinga
BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
21 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) shares surged 43.1% to $1.96 during Thursday's pre-market session. The ... 
Tags TLRY Market News MRNS
From Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Marinus Pharmaceuticals Inc (NASDAQ: MRNS) shares rose 60% to $2.17 in pre-market trading after the company announced all ... 
Tags CUK ENTA RAD
From Benzinga
BioXcel Therapeutics Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
BioXcel Therapeutics Announces BXCL501 Program Initiative for Prevention and Treatment of Acute Agitation using Wearable Digital Devices
From GlobeNewswire News Releases
71 Biggest Movers From Yesterday
Gainers T2 Biosystems, Inc. (NASDAQ: TTOO) shares jumped 82.5% to close at $2.61 on Wednesday after the company announced that it ... 
Tags Home Improvement Retail Consumer Discretionary ABIO
From Benzinga
We Did The Math IWO Can Go To $240
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BioXcel Therapeutics Receives FDA Orphan Drug Designation for BXCL701 for the Treatment of Acute Myeloid Leukemia (AML)
From GlobeNewswire News Releases
BioXcel Therapeutics Announces Award of Grant by U.S. Department of Defense’s (“DoD”) Congressionally Directed Medical Research Programs (“CDMRP”) for Development of BXCL501
From GlobeNewswire News Releases
Either Analysts Got The Components Wrong or Russell 2000 Headed 23% Higher
The financial media loves to get predictions from experts about where they think a given stock market index is headed. Some experts look at technical analysis patterns, others look at valuation... 
Tags ETFs
From ETF Channel
BioXcel Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
From GlobeNewswire News Releases
The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit ... 
Tags BCEL Trading Ideas LPTX
From Benzinga
BioXcel Therapeutics to Present at the Canaccord Genuity 2019 Annual Growth Conference
BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI) today announced that Dr. Vimal Mehta, Founder and Chief Executive Officer of BTI, will present [on its product candidates] at the Canaccord Genuity... 
From GlobeNewswire News Releases
BioXcel Therapeutics to Report Second Quarter and Half Year 2019 Financial Results and Business Update
Conference Call scheduled to discuss results on August 6, 2019 at 8:30 AM EDT 
From GlobeNewswire News Releases
BioXcel's CEO On BXCL501: 'This Is A Pretty Unique Drug'
BioXcel Therapeutics (NASDAQ: BTAI) is a biotech company that is using artificial intelligence to identify neuroscience and ... 
Tags Interview Market News Biotech
From Benzinga
BioXcel Therapeutics Announces BXCL501 Met Primary Endpoint in Phase 1b Placebo-Controlled Trial in the Treatment of Agitation in Patients with Schizophrenia
BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company utilizing novel artificial intelligence approaches to identify and advance the next wave of... 
From GlobeNewswire News Releases
BioXcel Therapeutics Added to Russell 3000® Index
BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI) today announced that the company has been added to the broad-market Russell 3000® Index following the conclusion of the 2019 Russell indexes annual... 
From GlobeNewswire News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.